Pharmx Technologies Ltd (PHX) — Cash Flow Quality Index
Pharmx Technologies Ltd (PHX) has a Cash Flow Quality Index of 5.80x as of June 2022. Operating cash flow of AU$478.50K exceeds net income of AU$82.50K, indicating high earnings quality where cash backs reported profits. Explore PHX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmx Technologies Ltd Cash Flow Quality Index (2007–2022)
Historical Cash Flow Quality Index for Pharmx Technologies Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PHX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharmx Technologies Ltd (2007–2022)
Year-by-year earnings quality comparison for Pharmx Technologies Ltd. For live market cap and the full company financial profile, see Pharmx Technologies Ltd (PHX) market capitalisation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 121.83x | AU$2.19 Million | AU$18.00K | ▲ +4103.7% |
| 2021 | 2.90x | AU$3.16 Million | AU$1.09 Million | ▲ +38.2% |
| 2020 | 2.10x | AU$369.00K | AU$176.00K | ▲ +58.5% |
| 2018 | 1.32x | AU$332.00K | AU$251.00K | ▲ +102.8% |
| 2016 | -47.04x | AU$-1.27 Million | AU$27.00K | ▼ -6264.2% |
| 2015 | 0.76x | AU$3.53 Million | AU$4.63 Million | ▼ -42.6% |
| 2014 | 1.33x | AU$5.68 Million | AU$4.27 Million | ▲ +27.7% |
| 2013 | 1.04x | AU$6.61 Million | AU$6.36 Million | ▲ +34.4% |
| 2012 | 0.77x | AU$4.67 Million | AU$6.03 Million | ▼ -63.1% |
| 2011 | 2.10x | AU$3.67 Million | AU$1.75 Million | ▲ +4.6% |
| 2010 | 2.01x | AU$2.26 Million | AU$1.13 Million | ▼ -69.0% |
| 2007 | 6.48x | AU$2.65 Million | AU$409.00K | — |